Skip to main content
. 2020 Mar 9;22(7):1094–1101. doi: 10.1111/dom.14004

Figure 1.

Figure 1

Study design (NCT02419612). DAPA, dapagliflozin; GLIM, glimepiride; IR, instant release; MET, metformin; SAXA, saxagliptin; XR, extended release